BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2342538)

  • 1. Severe combined immunodeficiency due to a specific defect in the production of interleukin-2.
    Weinberg K; Parkman R
    N Engl J Med; 1990 Jun; 322(24):1718-23. PubMed ID: 2342538
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary severe immunodeficiency due to impaired signal transduction in T cells.
    Schlesier M; Niemeyer C; Duffner U; Henschen M; Tanzi-Fetta R; Wolff-Vorbeck G; Dräger R; Brandis M; Peter HH
    Immunodeficiency; 1993; 4(1-4):133-6. PubMed ID: 8167687
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe combined immunodeficiency due to defective binding of the nuclear factor of activated T cells in T lymphocytes of two male siblings.
    Feske S; Müller JM; Graf D; Kroczek RA; Dräger R; Niemeyer C; Baeuerle PA; Peter HH; Schlesier M
    Eur J Immunol; 1996 Sep; 26(9):2119-26. PubMed ID: 8814256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief report: primary immunodeficiency caused by mutations in the gene encoding the CD3-gamma subunit of the T-lymphocyte receptor.
    Arnaiz-Villena A; Timon M; Corell A; Perez-Aciego P; Martin-Villa JM; Regueiro JR
    N Engl J Med; 1992 Aug; 327(8):529-33. PubMed ID: 1635567
    [No Abstract]   [Full Text] [Related]  

  • 5. [T cell receptor, immunoglobulin genes and immunodeficiency].
    Kurosawa Y
    Tanpakushitsu Kakusan Koso; 1991 Aug; 36(10):1741-6. PubMed ID: 1947183
    [No Abstract]   [Full Text] [Related]  

  • 6. Absence of interleukin 2 production in a severe combined immunodeficiency disease syndrome with T cells.
    DiSanto JP; Keever CA; Small TN; Nicols GL; O'Reilly RJ; Flomenberg N
    J Exp Med; 1990 May; 171(5):1697-704. PubMed ID: 2139699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired production of interleukins in patients with cell-mediated immunodeficiencies.
    Paganelli R; Aiuti F; Beverley PC; Levinsky RJ
    Clin Exp Immunol; 1983 Feb; 51(2):338-44. PubMed ID: 6601554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic effects of interleukin 2 in primary immunodeficiency diseases.
    Flomenberg N; Welte K; Mertelsmann R; Kernan N; Ciobanu N; Venuta S; Feldman S; Kruger G; Kirkpatrick D; Dupont B; O'Reilly R
    J Immunol; 1983 Jun; 130(6):2644-50. PubMed ID: 6222111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of interleukin-2 production in a patient with OKT4+ T-cell deficiency.
    Tsuchiya S; Imaizumi M; Minegishi M; Konno T; Tada K
    N Engl J Med; 1983 May; 308(21):1294. PubMed ID: 6601773
    [No Abstract]   [Full Text] [Related]  

  • 10. Abnormalities in the expression of T cell activation genes in patients with common variable immunodeficiency.
    Sneller MC; Strober W
    Trans Assoc Am Physicians; 1990; 103():163-73. PubMed ID: 2132528
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic analysis of the human CD3-epsilon gene in a T cell receptor/CD3 immunodeficiency.
    Soudais C; De Villartay JP; Le Deist F; Fischer A; Lisowska-Grospierre B
    Immunodeficiency; 1993; 4(1-4):117-9. PubMed ID: 8167684
    [No Abstract]   [Full Text] [Related]  

  • 12. Keratinocyte-derived T cell costimulation induces preferential production of IL-2 and IL-4 but not IFN-gamma.
    Goodman RE; Nestle F; Naidu YM; Green JM; Thompson CB; Nickoloff BJ; Turka LA
    J Immunol; 1994 Jun; 152(11):5189-98. PubMed ID: 7910619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune deficiency of the uremic patient.
    Chatenoud L; Herbelin A; Beaurain G; Descamps-Latscha B
    Adv Nephrol Necker Hosp; 1990; 19():259-74. PubMed ID: 2105582
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement of T lymphocyte differentiation in vitro by thymic extracts and purified polypeptides in severe combined immunodeficiency diseases.
    Incefy GS; Boumsell L; Kagan W; Goldstein G; Sousa MD; Smithwick E; O'Reilly R; Good RA
    Trans Assoc Am Physicians; 1975; 88():135-45. PubMed ID: 772925
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of T lymphocytes through the Ly-6 pathway is defective in A strain mice.
    Malek TR; Shevach EM; Danis KM
    J Immunol; 1989 Jul; 143(2):439-45. PubMed ID: 2525586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Severe combined immunodeficiency disease. I. Patients with SCID--clinical features and immunological findings].
    Matsuoka H; Torii S; Okada J; Mizuno T; Tsuge I; Katagiri M; Kishimoto M; Sato C; Matsuoka M; Suzuki S
    Arerugi; 1984 Dec; 33(12):1002-7. PubMed ID: 6335963
    [No Abstract]   [Full Text] [Related]  

  • 17. Hereditary deficiency of OKT4-positive cells: studies for mode of inheritance and lymphocyte functions.
    Fukuda T; Matsunaga M; Kurata A; Mine M; Ikari N; Katamine S; Kanazawa H; Eguchi K; Nagataki S
    Immunology; 1984 Dec; 53(4):643-9. PubMed ID: 6209207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between IL 2 synthesis and the proliferative response to PHA in different primary immunodeficiencies.
    López-Botet M; Fontán G; Garcia Rodriguez MC; de Landázuri MO
    J Immunol; 1982 Feb; 128(2):679-83. PubMed ID: 6976384
    [No Abstract]   [Full Text] [Related]  

  • 19. Proliferation in autologous mixed lymphocyte reactions, expression of HLA-class II antigen and serum immunomodulatory activity in patients with renal insufficiency on chronic dialysis.
    Puppo F; Gurreri G; Pattarini R; Ranise A; Indiveri F
    Allergol Immunopathol (Madr); 1991; 19(4):167-73. PubMed ID: 1840170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Common variable immunodeficiency].
    Saiki O
    Rinsho Byori; 1985 Nov; 33(11):1203-9. PubMed ID: 2419600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.